Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Renal Cell Carcinoma Market Report 2026-2030 & 2035: Increasing Immunotherapy and Precision Oncology Programs Drives Market Expansion, Reaching USD 6.09 Billion by 2030

April 1, 2026

Trends & Strategies Shaping the Sourcing Software Market, 2026-2030 & 2035, Featuring Strategic Analysis of IBM, Oracle, SAP SE, Workday, GEP, Coupa, Zycus, Ivalua and More

April 1, 2026

Ingram makes presence felt with birthday shutout

April 1, 2026

Outpatient Oncology Infusion Market Report 2026: Precision Oncology Driving the Market to Reach $20.21 Billion by 2030

April 1, 2026

Oncology Ablation Market Trends and Investment Opportunities, 2026-2030 & 2035

April 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » SNPS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Synopsys Investors Have Opportunity to Lead Class Action Lawsuit
Press Release

SNPS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Synopsys Investors Have Opportunity to Lead Class Action Lawsuit

By News RoomNovember 9, 20254 Mins Read
SNPS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Synopsys Investors Have Opportunity to Lead Class Action Lawsuit
Share
Facebook Twitter LinkedIn Pinterest Email

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Synopsys To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, Nov. 09, 2025 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) and reminds investors of the December 30, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the extent to which the Company’s increased focus on artificial intelligence customers, which require additional customization, was deteriorating the economics of its Design IP business; (2) that, as a result, “certain road map and resource decisions” were unlikely to “yield their intended results;” (3) that the foregoing had a material negative impact on financial results; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On September 9, 2025, after market hours, Synopsys released its third quarter 2025 financial results, revealing the Company’s “IP business underperformed expectations.” The Company reported quarterly revenue of $1.740 billion, missing its prior guidance of between $1.755 billion and $1.785 billion, and reported net income of $242.5 million, a 43% year-over-year decline from $425.9 million reported for third quarter 2024. Moreover, the Company reported its Design IP segment accounted for approximately 25% of revenue and came in at $426.6 million, a 7.7% decline year-over-year. Finally, management provided guidance which implied that Design IP revenues will decline by at least 5% on a full-year basis in fiscal 2025.

On this news, Synopsys’s stock price fell $216.59, or 35.8%, to close at $387.78 per share on September 10, 2025, on unusually heavy trading volume.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Synopsys’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Synopsys class action, go to www.faruqilaw.com/SNPS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/1c84fcf7-a77f-4c3f-a1dd-153f7bf3d4ac

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Renal Cell Carcinoma Market Report 2026-2030 & 2035: Increasing Immunotherapy and Precision Oncology Programs Drives Market Expansion, Reaching USD 6.09 Billion by 2030

Trends & Strategies Shaping the Sourcing Software Market, 2026-2030 & 2035, Featuring Strategic Analysis of IBM, Oracle, SAP SE, Workday, GEP, Coupa, Zycus, Ivalua and More

Outpatient Oncology Infusion Market Report 2026: Precision Oncology Driving the Market to Reach $20.21 Billion by 2030

Oncology Ablation Market Trends and Investment Opportunities, 2026-2030 & 2035

Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More

Bitget Brings Blockchain4Youth to IIT Delhi as Demand for Web3 Education Surges

Impact Senior Living Expands in Florida with Three More Communities

Scouting America Announces Second Annual National “Scouting for Clean Waterways” Initiative

Sorafenib Market Research Report 2026-2030 – Increasing Cancer Incidence Spurs Sorafenib Market Expansion

Editors Picks

Trends & Strategies Shaping the Sourcing Software Market, 2026-2030 & 2035, Featuring Strategic Analysis of IBM, Oracle, SAP SE, Workday, GEP, Coupa, Zycus, Ivalua and More

April 1, 2026

Ingram makes presence felt with birthday shutout

April 1, 2026

Outpatient Oncology Infusion Market Report 2026: Precision Oncology Driving the Market to Reach $20.21 Billion by 2030

April 1, 2026

Oncology Ablation Market Trends and Investment Opportunities, 2026-2030 & 2035

April 1, 2026

Latest News

Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More

April 1, 2026

Bitget Brings Blockchain4Youth to IIT Delhi as Demand for Web3 Education Surges

April 1, 2026

Impact Senior Living Expands in Florida with Three More Communities

April 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version